• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Cardiol Heart Vasc . Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent m

tetano

Editor, Senior Moderator
Int J Cardiol Heart Vasc


. 2021 Oct;36:100854.
doi: 10.1016/j.ijcha.2021.100854. Epub 2021 Aug 3.
Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement


Javier Urmeneta Ulloa[SUP] 1 2 [/SUP], Vicente Martínez de Vega[SUP] 2 [/SUP], Oscar Salvador Montañés[SUP] 1 [/SUP], Ana Álvarez Vázquez[SUP] 2 [/SUP], Cristina Sánchez-Enrique[SUP] 1 [/SUP], Sergio Hernández Jiménez[SUP] 1 [/SUP], Francisco Daniel Sancho García[SUP] 2 [/SUP], Luis López Ruiz[SUP] 2 [/SUP], Manuel Recio Rodríguez[SUP] 2 [/SUP], Gonzalo Pizarro[SUP] 3 4 [/SUP], Daniel Carnevali Ruiz[SUP] 5 [/SUP], José Ángel Cabrera[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Post-COVID-19 patients may incur myocardial involvement secondary to systemic inflammation. Our aim was to detect possible oedema/diffuse fibrosis using cardiac magnetic resonance imaging (CMR) mapping and to study myocardial deformation of the left ventricle (LV) using feature tracking (FT).
Methods: Prospective analysis of consecutively recruited post-COVID-19 patients undergoing CMR. T1 and T2 mapping sequences were acquired and FT analysis was performed using 2D steady-state free precession cine sequences. Statistical significance was set to p < 0.05.
Results: Included were 57 post-COVID-19 patients and 20 healthy controls, mean age 59 ± 15 years, men 80.7%. The most frequent risk factors were hypertension (33.3%) and dyslipidaemia (36.8%). The contact-to-CMR interval was 81 ± 27 days. LV ejection fraction (LVEF) was 61 ± 10%. Late gadolinium enhancement (LGE) was evident in 26.3% of patients (19.3%, non-ischaemic). T2 mapping values (suggestive of oedema) were higher in the study patients than in the controls (50.9 ± 4.3 ms vs 48 ± 1.9 ms, p < 0.01). No between-group differences were observed for native T1 nor for circumferential strain (CS) or radial strain (RS) values (18.6 ± 3.3% vs 19.2 ± 2.1% (p = 0.52) and 32.3 ± 8.1% vs 33.6 ± 7.1% (p = 0.9), respectively). A sub-group analysis for the contact-to-CMR interval (<8 weeks vs ≥ 8 weeks) showed that FT-CS (15.6 ± 2.2% vs 18.9 ± 2.6%, p < 0.01) and FT-RS (24.9 ± 5.8 vs 33.5 ± 7.2%, p < 0.01) values were lower for the shorter interval.
Conclusions: Post-COVID-19 patients compared to heathy controls had raised T2 values (related to oedema), but similar native T1, FT-CS and FT-RS values. FT-CS and FT-RS values were lower in post-COVID-19 patients undergoing CMR after < 8 weeks compared to ≥ 8 weeks.

Keywords: CMR, Cardiac-magnetic-resonance-imaging; COVID-19; COVID-19, coronavirus disease-2019; CRP, C-reactive-protein; CS, circumferential-strain; Cardiac magnetic resonance imaging; ECG, electrocardiogram; ECV, extracellular-volume; EGE, early-gadolinium-enhancement; FT, feature-tracking; Feature tracking; ICU, intensive-care-unit; IQR, interquartile-range; IR, inversion-recovery; LAX, long-axis-view; LGE, late-gadolinium-enhancement; LS, longitudinal-strain; LV, left-ventricle; LVEDV, LV end-diastolic-volume; LVEF, LV-Ejection-fraction; LVESV, LV-end-systolic-volume; MERS-CoV, Middle-East-respiratory-syndrome-coronavirus; Mapping; PCR, polymerase-chain-reaction; ROI, region-of-interest; RS, radial-strain; RV, right-ventricle; RVEDV, end-diastolic-volume; RVEF, RV-ejection-fraction; RVESV, RV-end-systolic-volume; SARS-CoV-2, severe-acute-respiratory-syndrome-coronavirus-2; SAX, short-axis-view; SCLS, systemic-capillary-leak-syndrome; SD, standard-deviation; SIRS, systemic-inflammatory-response-syndrome; SSFP, steady-state-free-precession; STIR, short-tau-inversion-recovery; TR, repetition-time; TTE, transthoracic-echocardiography.
 
Back
Top Bottom